Merck Manual

Please confirm that you are a health care professional

honeypot link

PAPA Syndrome

By

Gil Amarilyo

, MD, Tel Aviv University

Reviewed/Revised Dec 2023
View PATIENT EDUCATION
Topic Resources

PAPA syndrome is caused by

  • Mutations in the proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1) gene on chromosome 15q

The mutated gene produces a hyperphosphorylated protein that binds excessively to pyrin, thus restricting pyrin’s anti-inflammatory activity, which possibly involves inhibiting neutrophil activation and chemotaxis by blocking activation of inflammasomes. PSTPIP1 variants have been identified in a broad spectrum of phenotypes such as PAPASH (pyoderma gangrenosum, acne, and suppurative hidradenitis with pyogenic arthritis ) and PASH (pyoderma gangrenosum, acne, and suppurative hidradenitis without pyogenic arthritis) (1 General references PAPA (pyogenic arthritis, pyoderma gangrenosum, and acne) syndrome is an autosomal dominant disorder that affects the skin and joints. PAPA syndrome is caused by Mutations in the proline-serine-threonine... read more General references ).

Arthritis begins in the first decade of life and is progressively destructive. Episodes of mild trauma may trigger the arthritis. Poorly healing ulcers with undermined edges may appear, often at sites of injury (eg, at vaccination sites). Acne is usually nodulocystic and, if untreated, causes scarring. By puberty, arthritis tends to subside, and cutaneous symptoms predominate.

Diagnosis of PAPA syndrome is based on clinical findings and a family history. The ulcers may be biopsied. Biopsy shows superficial ulceration and neutrophilic inflammation. Genetic testing for mutations in the PSTPIP1 gene may support the diagnosis.

General references

  • 1. Boursier G, Piram M, Rittore C, et al: Phenotypic associations of PSTPIP1 sequence variants in PSTPIP1-associated autoinflammatory diseases. J Invest Dermatol 141(5):1141–1147, 2021. doi: 10.1016/j.jid.2020.08.028

  • 2. Cugno M, Borghi A, Marzano AV: PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment. Am J Clin Dermatol 18(4):555-562, 2017. doi: 10.1007/s40257-017-0265-1

Drugs Mentioned In This Article

Drug Name Select Trade
Enbrel
ABRILADA, AMJEVITA , CYLTEZO, HADLIMA, Hulio, Hulio PEN, Humira, HUMIRA PEN, Hyrimoz, Idacio, YUFLYMA, YUSIMRY
AVSOLA, INFLECTRA, Remicade, RENFLEXIS, Zymfentra
Kineret
Emtet-500, Panmycin, Sumycin
Absorica, Absorica LD, Accutane, Amnesteem , Claravis , MYORISAN, Sotret, ZENATANE
View PATIENT EDUCATION
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz! 
iOS ANDROID
iOS ANDROID
iOS ANDROID
TOP